Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Vicore Pharma Holding AB

Closing information (x1000 SEK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 358 More Arrow 476 More Arrow 2,563
Earnings before taxes -311,326 More Arrow -288,806 Less Arrow -296,735
EBITDA -318,150 More Arrow -287,368 Less Arrow -291,220
Total assets 497,838 Less Arrow 338,007 More Arrow 451,168
Current assets 495,595 Less Arrow 269,790 More Arrow 377,931
Current liabilities 38,781 More Arrow 46,292 More Arrow 65,570
Equity capital 455,389 Less Arrow 289,083 More Arrow 383,316
- share capital 55,861 Less Arrow 40,924 Less Arrow 35,880
Employees (average) 25 Less Arrow 21 Less Arrow 16

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 91.5% Less Arrow 85.5% Less Arrow 85.0%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -62.5% Less Arrow -85.3% More Arrow -65.2%
Current ratio 1277.9% Less Arrow 582.8% Less Arrow 576.4%
Return on equity (ROE) -68.4% Less Arrow -99.9% More Arrow -77.4%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 4 More Arrow 5 Less Arrow 3
Chg. No. of employees % 19% More Arrow 31% Less Arrow 23%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.